COPYRINE ALKALOIDS - SYNTHESIS, SPECTROSCOPIC CHARACTERIZATION, AND ANTIMYCOTIC - ANTIMYCOBACTERIAL ACTIVITY OF A-RING-FUNCTIONALIZED AND B-RING-FUNCTIONALIZED SAMPANGINES

被引:110
作者
PETERSON, JR
ZJAWIONY, JK
LIU, SC
HUFFORD, CD
CLARK, AM
ROGERS, RD
机构
[1] UNIV MISSISSIPPI,SCH PHARM,DEPT PHARMACOGNOSY,UNIVERSITY,MS 38677
[2] UNIV MISSISSIPPI,SCH PHARM,PHARMACEUT SCI RES INST,UNIVERSITY,MS 38677
[3] NO ILLINOIS UNIV,DEPT CHEM,DE KALB,IL 60115
关键词
D O I
10.1021/jm00100a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several A- and B-ring-substituted sampangines were synthesized and evaluated for antifungal and antimycobacterial activity against AIDS-related opportunistic infection pathogens. Electrophilic halogenation provided a channel for structural elaboration of the sampangine B-ring at position 4, while the synthesis of A-ring 3-substituted sampangines and benzo[4,5]sampangine (24) were achieved from the corresponding functionalized cleistopholines. Two-dimensional NMR spectroscopy was used to rigorously characterize the A- and B-ring substituent patterns. Structure-activity relationship studies revealed the activity of the sampangines was enhanced by the presence of a substituent at position 3 or by a 4,5-benzo group.
引用
收藏
页码:4069 / 4077
页数:9
相关论文
共 37 条
[1]   TREATMENT OF INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ARMSTRONG, D ;
GOLD, JWM ;
DRYJANSKI, J ;
WHIMBEY, E ;
POLSKY, B ;
HAWKINS, C ;
BROWN, AE ;
BERNARD, E ;
KIEHN, TE .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (05) :738-743
[2]  
BENNETT DR, 1983, DRUG EVALUATION, P177
[3]   TOTAL SYNTHESIS OF THE PENTACYCLIC ALKALOID ASCIDIDEMIN [J].
BRACHER, F .
HETEROCYCLES, 1989, 29 (11) :2093-2095
[4]  
BRACHER F, 1989, LIEBIGS ANN CHEM, P87
[5]   CONSTITUENTS OF EUPOMATIA SPECIES .12. ISOLATION OF CONSTITUENTS OF THE TUBERS AND AERIAL PARTS OF EUPOMATIA-BENNETTII AND DETERMINATION OF THE STRUCTURES OF NEW ALKALOIDS FROM THE AERIAL PARTS OF E-BENNETTII AND MINOR ALKALOIDS OF E-LAURINA [J].
CARROLL, AR ;
TAYLOR, WC .
AUSTRALIAN JOURNAL OF CHEMISTRY, 1991, 44 (11) :1615-1626
[6]   TREATMENT OF CRYPTOCOCCAL MENINGITIS WITH COMBINATION AMPHOTERICIN-B AND FLUCYTOSINE FOR 4 AS COMPARED WITH 6 WEEKS [J].
DISMUKES, WE ;
CLOUD, G ;
GALLIS, HA ;
KERKERING, TM ;
MEDOFF, G ;
CRAVEN, PC ;
KAPLOWITZ, LG ;
FISHER, JF ;
GREGG, CR ;
BOWLES, CA ;
SHADOMY, S ;
STAMM, AM ;
DIASIO, RB ;
KAUFMAN, L ;
SOONG, SJ ;
BLACKWELDER, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) :334-341
[7]   CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS [J].
DISMUKES, WE .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :624-628
[8]  
DROUHET E, 1987, REV INFECT DIS, V9, pS4
[9]  
FURIO MM, 1985, CLIN PHARMACY, V4, P539
[10]   MYCOBACTERIUM-AVIUM-INTRACELLULARE - A CAUSE OF DISSEMINATED LIFE-THREATENING INFECTION IN HOMOSEXUALS AND DRUG-ABUSERS [J].
GREENE, JB ;
SIDHU, GS ;
LEWIN, S ;
LEVINE, JF ;
MASUR, H ;
SIMBERKOFF, MS ;
NICHOLAS, P ;
GOOD, RC ;
ZOLLAPAZNER, SB ;
POLLOCK, AA ;
TAPPER, ML ;
HOLZMAN, RS .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (04) :539-546